NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, TO U.S. PERSONS OR IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.
10 August 2018
Axiom European Financial Debt Fund Limited
Issue of equity
The Board of Axiom European Financial Debt Fund Limited (the "Company") is pleased to announce that the Company has allotted, subject to admission, 1,223,499 new ordinary shares of no par value in the captial of the Company (the "New Shares").
The New Shares were issued at a price of 98.50 pence per New Share, representing a 2.9% premium to the latest published estimated cum income ex-dividend NAV per Share of 95.74 pence announced on 9 August 2018.
The New Shares will, when issued, be credited as fully paid and will rank pari passu in all respects with the existing ordinary shares. Application has been made for the New Shares to be admitted to trading on the Specialist Fund Segment of the London Stock Exchange's main market for listed securities ("Admission"). It is expected that Admission will become effective and dealings in the new Shares will commence at 8.00 a.m. on 15 August 2018.
Following Admission, the total number of ordinary shares in issue will be 85,452,024 and the total number of voting rights in the Company will be 85,452,024. There are no ordinary shares held in treasury. The above figure of 85,452,024 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.
For further information please contact:
Axiom Alternative Investments SARL
David Benamou, Managing Partner
Jerome Legras, Managing Partner
+44(0)20 3807 0670
Winterflood Securities Limited
+44(0)20 3100 0000
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.